Document is current
Any future updates will be listed below
-
Authors
Hou, Jiabao
Li, Hongle
Ma, Shuxiang
He, Zhen
Yang, Sen
Hao, Lidan
Zhou, Hanqiong
Zhang, Zhe
Han, Jing
Wang, Li
Wang, Qiming http://orcid.org/0000-0003-3217-1077
-
Funding
Funding for this research was provided by:
ZHONGYUAN QIANREN JIHUA (ZYQR201912118)
Medical Key Laboratory of Refractory Lung Cancer of Henan Province ([2020]27)
Engineering Technology Research Center of Refractory Lung Cancer Drug Therapy in Henan Province ([2020]4)
Leading Talent Cultivation Project of Henan Health Science and Technology Innovation Talents (YXKC2020009)
Henan International Joint Laboratory of Drug Resistance and Reversal of Targeted Therapy for Lung Cancer ([2021]10)
Key Research and Development and Promotion Projects of Henan Province (212102310738)
- License Information
-
More Information
Article History
Received: 21 November 2021
Accepted: 29 March 2022
First Online: 13 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.
